FDA drug regulation workshop
Executive Summary
FDA will hold a two-day public meeting June 8-9 to provide information about drug and device regulation to the regulated industry. Called "Drugs and Devices - Promoting and Protecting the Public Health Through Risk Management and Product Cycle Improvement," the workshop will address: a risk management approach to consumer protection and industry regulation; how quality management systems (including corrective and preventive action) contribute to product cycle improvement; supplier management and component controls for drugs and devices; adverse drug event reporting requirements; medical device reporting requirements; recalls, corrections and removals; and complaint handling from the FDA investigator's perspective
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.